Premium
Clinical research potential in V ictorian hospitals: the V ictorian clinician researcher needs analysis survey
Author(s) -
Hiscock H.,
Ledgerwood K.,
Danchin M.,
Ekinci E.,
Johnson E.,
Wilson A.
Publication year - 2014
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12396
Subject(s) - medicine , enabling , clinical research , survey research , family medicine , medical education , nursing , psychology , pathology , psychiatry , applied psychology
Background The 2012 M c K eon Review highlighted the role of clinician researchers in patient based research and the need to foster this capacity. While anecdotal evidence suggests that clinician researchers are under threat and underfunded, Australian data on barriers and enablers of clinician‐led research are scant. Aims To describe (i) characteristics of clinician researchers; (ii) for research‐active clinicians: areas of research, barriers/enablers of research and factors associated with funding success; and (iii) for research‐inactive clinicians: enablers of future research. Methods An online survey distributed through the B io21 C luster to clinicians (doctors, nurses, allied health professionals) in 15 V ictorian hospitals between N ovember 2011 and J anuary 2012. Results Seven hundred and seventy of 1027 (75%) of respondents were research‐active and were more likely to be male, medical doctors, aged 45–54 years, to work full‐time and have a higher degree (all P < 0.01). Of clinicians with a higher degree, 28% were research‐inactive. Clinicians identified protected research time (50%), designated research space (42%), clinical trial coordinators (35%), institutional funding (34%) and mentoring (33%) as critical enablers of research. Research‐inactive clinicians identified protected research time as the key enabler of future research. Conclusions To realise recommendations in the M c K eon Review, hospitals and research bodies will need to protect research time and provide space and funding. Engaging research‐inactive clinicians will build research capacity.